期刊
APOPTOSIS
卷 27, 期 5-6, 页码 297-310出版社
SPRINGER
DOI: 10.1007/s10495-022-01721-4
关键词
NOB; Cell death; Cancer; Apoptosis; Autophagy; Pyroptosis
资金
- Cooperative Foundation of Shaoyang University
- Scientific Research Project of Hunan Provincial Education Department [20B526]
Cancer resistance to therapy is a significant challenge in cancer treatment, involving reduced induction of cell death and decreased response to anti-tumor immunity. Nobiletin can induce endogenous ROS generation, leading to damage to critical macromolecules and ultimately cell death. Additionally, NOB can induce cancer cell killing by modulating multiple mechanisms of cell death.
Cancer resistance to therapy is a big issue in cancer therapy. Tumours may develop some mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer cells may show a low expression and activity of tumour suppressor genes and a low response to anti-tumour immunity. These mutations can increase the resistance of cancer cells to programmed cell death mechanisms such as apoptosis, ferroptosis, pyroptosis, autophagic cell death, and some others. The upregulation of some mediators and transcription factors such as Akt, nuclear factor of kappa B, signal transducer and activator of transcription 3, Bcl-2, and others can inhibit cell death in cancer cells. Using adjuvants to induce the killing of cancer cells is an interesting strategy in cancer therapy. Nobiletin (NOB) is a herbal-derived agent with fascinating anti-cancer properties. It has been shown to induce the generation of endogenous ROS by cancer cells, leading to damage to critical macromolecules and finally cell death. NOB may induce the activity of p53 and pro-apoptosis mediators, and also inhibit the expression and nuclear translocation of anti-apoptosis mediators. In addition, NOB may induce cancer cell killing by modulating other mechanisms that are involved in programmed cell death mechanisms. This review aims to discuss the cellular and molecular mechanisms of the programmed cell death in cancer by NOB via modulating different types of cell death in cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据